Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review

BACKGROUND: Intra-abdominal desmoplastic small round cell tumors (IADSRCT) are rare and aggressive neoplasia that are resistant to chemotherapy. Anlotinib is an oral multi-target tyrosine kinase inhibitor that also has anti-angiogenic and anti-proliferative properties. In this article, we report on...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ke, Liu, Xia, Chen, Ye, Zhou, Kexun, Li, ZhiPing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386944/
https://www.ncbi.nlm.nih.gov/pubmed/35978277
http://dx.doi.org/10.1186/s12876-022-02463-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386944/
https://www.ncbi.nlm.nih.gov/pubmed/35978277
http://dx.doi.org/10.1186/s12876-022-02463-y

Ejemplares similares